Events, By Category and Date:
» Go to news mainSecuring Safe Supply During COVID‑19 and Beyond: Scoping Review and Knowledge Mobilization
Posted by nte on
January 12, 2021
in
In Action
Synthesis Title: Securing Safe Supply During COVID-19 and Beyond: Scoping Review and Knowledge Mobilization Nominated Principal Applicant (name and affiliation):
Matthew Herder, Director, Health Law Institute, Schulich School of Law, Dalhousie University; Associate Professor, Department of Pharmacology, Faculty of Medicine, Dalhousie University
Key Messages
- Restrictive laws and fear of discipline by professional bodies appear to limit access to safe supply.
- Facilitators such as regulatory exemptions are insufficient by themselves, to improve access to safe supply.
- In some respects, there is broad agreement between the literature reviewed and PWUD expertise whereas, in other cases, there is a disconnect between the bodies of knowledge about the barriers to implementing safe supply. To ensure this disconnect does not misdirect resources toward initiatives that do not respond to the barriers that are encountered, PWUD should be represented and integrated directly into efforts to improve access to safe supply
Read bullet point summary here and more extensive Executive Lay Summary here.
Recent News
- On what basis did Health Canada approve OxyContin in 1996? A retrospective analysis of regulatory data
- Matthew Herder Resigns from Patented Medicine Prices Review Board
- Permissive regulation: A critical review of the regulatory history of buprenorphine formulations in Canada
- Fair pricing of “old” orphan drugs: considerations for Canada’s orphan drug policy
- Podcast or Perish: Episode 040: Françoise Baylis
- Bioethicist Françoise Baylis asks why humans think 'they can just take everything'
- Killam Prize winners discuss research in Canada
- World‑renowned Dalhousie bioethicist and battery pioneer win prestigious Killam Prize